valganciclovir [Valcyte]

DRUG5 trials

Sponsors

Hoffmann-La Roche

Conditions

Cytomegalovirus InfectionsCytomegalovirus Infections, Heart TransplantationKidney Transplantation, Cytomegalovirus Infections

Phase 1

A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.

CompletedNCT00377741

Hoffmann-La RocheCytomegalovirus Infections

Start: 2004-12-31End: 2006-06-30Updated: 2015-12-31

A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age

CompletedNCT01165580

Hoffmann-La RocheCytomegalovirus Infections, Heart Transplantation

Start: 2011-05-31End: 2013-09-30Updated: 2016-11-02

Phase 2

A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients

CompletedNCT00090766

Hoffmann-La RocheCytomegalovirus Infections

Start: 2004-05-31End: 2005-05-31Updated: 2016-10-31

Phase 4

VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

CompletedNCT00431353

Hoffmann-La RocheCytomegalovirus Infections

Start: 2004-04-30End: 2008-08-31Updated: 2016-11-02

A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients

CompletedNCT01376804

Hoffmann-La RocheKidney Transplantation, Cytomegalovirus Infections

Start: 2011-07-31End: 2013-05-31Updated: 2017-07-11

Related Papers

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study

Clinical Infectious Diseases2018-10-03212 citations

Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.

2013-04-089 citations

Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients.

2013-02-1555 citations